KDM1A and neoplasm: Then, in checkpoint-blocked refractory mouse melanoma, histone demethylase LSD1 depletion enhanced tumor immunogenicity and T-cell infiltration in poorly immunogenic tumors and elicited a significant response to anti-PD-1 treatment [27].